ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Nextpharma Technologies Limited

Nextpharma Technologies Limited is a dormant company incorporated on 27 October 2000 with the registered office located in London, City of London. Nextpharma Technologies Limited was registered 25 years ago.
Status
Dormant
Dormant since 13 years ago
Company No
04100590
Private limited company
Age
25 years
Incorporated 27 October 2000
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 27 October 2025 (10 days ago)
Next confirmation dated 27 October 2026
Due by 10 November 2026 (1 year remaining)
Last change occurred 9 years ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Dormant
Next accounts for period 31 December 2025
Due by 30 September 2026 (10 months remaining)
Address
4th Floor 95 Gresham Street
London
EC2V 7AB
United Kingdom
Address changed on 5 Mar 2025 (8 months ago)
Previous address was Lynton House 7-12 Tavistock Square London WC1H 9LT United Kingdom
Telephone
01483479120
Email
Available in Endole App
People
Officers
2
Shareholders
1
Controllers (PSC)
1
Director • Chief Executive • Dutch • Lives in Netherlands • Born in Jul 1958
Mr Seamus Philip Fitzpatrick
PSC • British,Irish • Lives in England • Born in Nov 1966
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Nextpharma Technologies Holding Limited
Peter Arend William Burema is a mutual person.
Active
Nextpharma Holdings Ltd
Peter Arend William Burema is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£0
Same as previous period
Total Liabilities
-£1.65M
Same as previous period
Net Assets
-£1.65M
Same as previous period
Debt Ratio (%)
Unreported
Latest Activity
Confirmation Submitted
9 Days Ago on 28 Oct 2025
Mr Peter Arend William Burema Details Changed
23 Days Ago on 14 Oct 2025
Mr Seamus Philip Fitzpatrick (PSC) Details Changed
23 Days Ago on 14 Oct 2025
Dormant Accounts Submitted
1 Month Ago on 4 Oct 2025
Mr Peter Arend William Burema Details Changed
1 Month Ago on 29 Sep 2025
Registered Address Changed
8 Months Ago on 5 Mar 2025
Mr Peter Arend William Burema Details Changed
9 Months Ago on 27 Jan 2025
Confirmation Submitted
1 Year Ago on 28 Oct 2024
Mr Peter Arend William Burema Details Changed
1 Year Ago on 28 Oct 2024
Dormant Accounts Submitted
1 Year Ago on 8 Oct 2024
Get Credit Report
Discover Nextpharma Technologies Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Confirmation statement made on 27 October 2025 with no updates
Submitted on 28 Oct 2025
Change of details for Mr Seamus Philip Fitzpatrick as a person with significant control on 14 October 2025
Submitted on 14 Oct 2025
Director's details changed for Mr Peter Arend William Burema on 14 October 2025
Submitted on 14 Oct 2025
Accounts for a dormant company made up to 31 December 2024
Submitted on 4 Oct 2025
Director's details changed for Mr Peter Arend William Burema on 29 September 2025
Submitted on 29 Sep 2025
Registered office address changed from Lynton House 7-12 Tavistock Square London WC1H 9LT United Kingdom to 4th Floor 95 Gresham Street London EC2V 7AB on 5 March 2025
Submitted on 5 Mar 2025
Director's details changed for Mr Peter Arend William Burema on 27 January 2025
Submitted on 29 Jan 2025
Director's details changed for Mr Peter Arend William Burema on 28 October 2024
Submitted on 28 Oct 2024
Confirmation statement made on 27 October 2024 with no updates
Submitted on 28 Oct 2024
Accounts for a dormant company made up to 31 December 2023
Submitted on 8 Oct 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year